We use cookies to ensure the website works properly and to improve your experience. By continuing to use the website, you agree to their use.
Для размещения заказа оставьте ваш номер телефона. Мы с вами свяжемся в ближайшее время
Рассчитать стоимость заказа
Оставьте свои контакты и мы свяжемся с вами в ближайшее время
RAPID Measles-IgG ELISA
Registration Certificate: № RZN 2024/25209
Enzyme-Linked Immunosorbent Assay for qualitative and quantitative detection of IgG antibodies to Measles virus in human serum or plasma.
The Current Diagnostic Landscape
Measles is one of the most contagious viral diseases, leading to severe complications and death despite existing vaccinations. According to WHO estimates, in 2023, there were approximately 10.3 million measles cases and 107,500 deaths. The rise in incidence is driven by vaccine hesitancy, leaving millions of children unvaccinated.
Measles IgG is an objective marker of past infection or post-vaccination immunity. Serological monitoring of IgG via the ELISA method is used to identify vulnerable groups and manage preventive measures.
Measles IgG is an objective marker of past infection or post-vaccination immunity. Serological monitoring of IgG via the ELISA method is used to identify vulnerable groups and manage preventive measures.
Clinical Impact & Benefits
01
SUSCEPTIBILITY SCREENING
The IgG test quickly determines immune status: a positive result confirms protection following illness or vaccination, while a negative result indicates susceptibility to infection and the need for preventive measures.
02
IMMUNITY STRENGTH ASSESSMENT
Quantitative IgG determination identifies "low/borderline" antibody levels, helping to prioritize revaccination.
03
MONITORING HIGH-RISK GROUPS
IgG detection via the ELISA method is a fundamental tool for serological monitoring.
Key Advantages
Analytical Sensitivity (LOD) — 0.03 IU/ml
Color-coded reagents to minimize operator errors
Ready-to-use reagents for streamlined workflow
Extended shelf life reduces the risk of disposal and simplifies procurement planning
Technical Specifications
Total Incubation Time:
70−75 minutes
Analytical Sensitivity / Limit of Detection (LoD):
0.03 IU/mL
Coefficient of Variation (CV):
8%
Compatibility:
Fully compatible with ELISA analyzers
Shelf Life:
18 months
Submit a request to receive a commercial offer
We will contact you shortly
Related Products
